Caraloe Posts Sales Increases for 2Q02

Caraloe Posts Sales Increases for 2Q02

IRVING, Texas--While Carrington Laboratories Inc.(NASDAQ:CARN) reported a loss for its second quarter (2Q02), ended June 30 andreported Aug. 14, its Caraloe subsidiary experienced an increase in raw materialsales and contract manufacturing.

For the quarter, Carrington posted $4.3 million in sales, thesame as in 2Q01, although the company had a net loss of $858,000, or $.09 lostper diluted share, compared to 2Q01's net profit of $60,000, or $.01 earned perdiluted share. Caraloe, on the other hand, had sales that increased 29 percentto $2.2 million from $1.7 million logged in the same period last year. This wasdue to raw material sales growing 7 percent and contract manufacturing businessincreasing 154 percent. However, these gains were offset by a 17-percent declinein sales of the company's wound and skin care products due to decreased demand.The company expects market softness for wound care orders to continue until4Q02, when international orders are projected to increase.